Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Recently Added News

3/15/2024
BreakingMyopiaRefractiveRegulation
Santen Files for Marketing Approval in Japan for Atropine Drops to Delay Myopia
Santen Files for Marketing Approval in Japan for Atropine Drops to Delay Myopia

Santen Pharmaceutical announced Feb. 28 that it had filed for marketing approval in Japan of DE-127 (0.025% atropine sulfate hydrate eye drop), designed to slow the progression of myopia. The produ...

3/15/2024
BreakingCataractDry EyeGlaucomaRevenueSurgical
2023 Ophthalmic Revenue Roundup for Sight Sciences and Ocular Therapeutix
2023 Ophthalmic Revenue Roundup for Sight Sciences and Ocular Therapeutix

Sight Sciences reported March 7 that it generated 2023 total revenue of $81.1 million, an increase of 14 percent over $71.3 million in 2022. Surgical glaucoma revenue in 2023 was $74.3 million, a 1...

3/15/2024
BreakingRegulation
US Funding Bill Halves Medicare Reimbursement Cut for Rest of 2024
US Funding Bill Halves Medicare Reimbursement Cut for Rest of 2024

US lawmakers passed a partial government funding bill on March 8 that included a provision mitigating cuts to Medicare physician reimbursement in effect since Jan. 1. The legislation changes the re...

3/15/2024
BreakingOptometryRegulation
South Dakota Expands Optometrists’ Scope to Include SLT, YAG, Incisions
South Dakota Expands Optometrists’ Scope to Include SLT, YAG, Incisions

South Dakota Gov. Kristi Noem on March 4 signed into law a measure expanding the scope of practice of optometrists in the state. HB 1099 allows doctors of optometry to administer injections around ...

3/15/2024
BreakingDealsIndustry
Athyrium Takes Control of Upneeq Maker RVL Inc. as Parent Winds Down
Athyrium Takes Control of Upneeq Maker RVL Inc. as Parent Winds Down

RVL Pharmaceuticals Inc., of New Jersey, formerly a subsidiary of publicly held RVL Pharmaceuticals plc, is now owned by Athyrium Capital Management after emerging from Chapter 11 bankruptcy procee...

3/15/2024
BreakingCataractDealsDry EyePharma
NovaBay, Eyenovia Team Up to Co-promote Ophthalmic Products
NovaBay, Eyenovia Team Up to Co-promote Ophthalmic Products

Eyenovia and NovaBay Pharmaceuticals announced March 13 the signing of a co-promotion agreement to commercialize their prescription ophthalmic products. Under the agreement, NovaBay will market Eye...

3/15/2024
BiosimilarsBreakingRegulationRetina
Formycon’s Ranibizumab Biosimilar Gains Approval in Saudi Arabia, Will Be Marketed as Ravegza
Formycon’s Ranibizumab Biosimilar Gains Approval in Saudi Arabia, Will Be Marketed as Ravegza

Germany’s Formycon announced March 11 that FYB201 (ranibizumab), a biosimilar to Lucentis, had received marketing authorization from the Saudi Food & Drug Authority. Jordan’s MS Pharma is Formycon’...

3/15/2024
BreakingCataractIOLSurgical
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations

Alcon reported March 6 that the AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) had surpassed more than 1 million implantations worldwide. According to...

3/15/2024
BreakingDry EyeIndustry
Richard Lindstrom, MD, Becomes Chairman of Surface Ophthalmics
Richard Lindstrom, MD, Becomes Chairman of Surface Ophthalmics

Surface Ophthalmics, of Pleasanton, California, has named co-founder and director Richard Lindstrom, MD, as chairman. The company, which is developing dry eye drugs, was formed in 2018. Lindstrom w...

3/15/2024
BreakingCornealDry EyeIndustry
Vital Tears Appoints Joseph Tauber, MD, as Chief Medical Officer
Vital Tears Appoints Joseph Tauber, MD, as Chief Medical Officer

Vital Tears announced March 6 that it had appointed Joseph Tauber, MD, as its chief medical officer. In 2023, Vital Tears added mobile phlebotomy services to its system of providing autologous seru...

3/8/2024
BreakingCataractPharmaRegulation
US FDA Approves Clobetasol Propionate Eye Drops for Postsurgical Pain, Inflammation
US FDA Approves Clobetasol Propionate Eye Drops for Postsurgical Pain, Inflammation

Taiwan-based Formosa Pharmaceuticals announced March 4 that the US FDA had approved clobetasol propionate ophthalmic suspension 0.05% (APP13007) for inflammation and pain following ocular surgery. ...

3/8/2024
BiosimilarsBreakingIOLLaserOcular CancerRetinaRevenue
2023 Ophthalmic Revenue Roundup for Immunocore, RxSight, Lensar, and Biogen
2023 Ophthalmic Revenue Roundup for Immunocore, RxSight, Lensar, and Biogen

UK-headquartered Immunocore reported Feb. 28 that its 2023 net product revenue from Kimmtrak (tebentafusp) was $238.7 million, a 70 percent increase over $140.7 million in 2022. The 2023 total was ...

Past News Stories

9/8/2023
BreakingCataractEuropeGlaucomaIndiaIndustryMeetingRefractiveRetina
2024 Ophthalmic Meetings Calendar
2024 Ophthalmic Meetings Calendar

Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.

3/8/2024
BreakingRefractiveRegulationSurgical
FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads
FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads

The Federal Trade Commission has sent notices to about 160 thousand individuals who received LASIK consultations at LasikPlus or Joffe MediCenter that they may be eligible for a settlement payout. ...

3/8/2024
BreakingCornealRegulationRetina
US FDA Approves Supplemental NDA for Pre-filled Acthar Gel Self-Injector
US FDA Approves Supplemental NDA for Pre-filled Acthar Gel Self-Injector

Ireland-based Mallinckrodt announced March 1 that the US FDA had approved its supplemental new drug application (sNDA) for the H.P. Acthar Gel single-dose pre-filled SelfJect injector. SelfJect pro...

3/8/2024
BreakingGlaucomaPharmaSurgical
Celanese Announces Commercial Launch of Glaukos’ iDose TR Travoprost Implant
Celanese Announces Commercial Launch of Glaukos’ iDose TR Travoprost Implant

Celanese announced the commercial launch Feb. 29 of Glaukos’ iDose TR intracameral travoprost implant for glaucoma. Celanese, a global specialty materials and chemical company based in Dallas, Texa...

3/8/2024
BreakingGene TherapyRetinaStudy
Oculogenex’ Preclinical Retinal Gene Therapy Heads to Space with Mouse Model
Oculogenex’ Preclinical Retinal Gene Therapy Heads to Space with Mouse Model

Oculogenex, a California company developing a regenerative gene therapy for age-related macular degeneration (AMD), is sending its preclinical work into space. The company’s gene therapy candidate ...

3/8/2024
BreakingRetinaStudy
Blindness from Some Inherited Eye Diseases May Be Caused by Gut Bacteria
Blindness from Some Inherited Eye Diseases May Be Caused by Gut Bacteria

Sight loss in certain inherited eye diseases may be caused by gut bacteria, opening the door for potential treatment with antimicrobials, according to a new study in mice co-led by a researcher at ...

3/8/2024
BreakingDry EyeFunding
Tarsus Prices $100 Million Public Offering
Tarsus Prices $100 Million Public Offering

Tarsus Pharmaceuticals, of Irvine, California, announced March 1 that it had priced an underwritten public offering of shares and warrants, with expected gross proceeds of $100 million. Goldman Sac...

3/8/2024
BreakingIndustryRetina
EyePoint Appoints Ramiro Ribeiro, MD, PhD, as Chief Medical Officer
EyePoint Appoints Ramiro Ribeiro, MD, PhD, as Chief Medical Officer

EyePoint Pharmaceuticals announced March 4 that it had appointed retina specialist Ramiro Ribeiro, MD, PhD, as chief medical officer. Ribeiro succeeds Dario Paggiarino, MD, who had served in the ro...

3/1/2024
BreakingCornealDry EyeGlaucomaIOLRefractiveRetinaRevenueSurgical
2023 Ophthalmic Revenue Roundup for Alcon, Bausch + Lomb, STAAR, Glaukos, Apellis, and Tarsus
2023 Ophthalmic Revenue Roundup for Alcon, Bausch + Lomb, STAAR, Glaukos, Apellis, and Tarsus

Alcon reported Feb. 27 that its full year 2023 net sales totaled $9.4 billion, an 8 percent increase (+10 percent cc) over $8.7 billion in 2022. Q4-2023 sales were $2.3 billion, an 8 percent increa...

3/1/2024
BreakingCornealGlaucomaSurgical
CorNeat Vision Launches EverPatch Ophthalmic Graft Material in the US
CorNeat Vision Launches EverPatch Ophthalmic Graft Material in the US

Israel-based CorNeat Vision announced Feb. 27 that it had launched itsEverPatch scleral reinforcement patch in the US. The device was cleared by the US FDA in June 2023. The graft is the first synt...

3/1/2024
BreakingDry EyeIndiaRegulation
Eye Ointments Sold at Walmart, CVS Recalled Due to Infection Risk
Eye Ointments Sold at Walmart, CVS Recalled Due to Infection Risk

India’s Brassica Pharma announced Feb. 12 that it was voluntarily recalling eye ointments sold by retailers such as Walmart and CVS due to a danger of infection. The company said an inspection by t...

3/1/2024
BreakingIndustryPharma
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO

AbbVie reported Feb. 20 that it had named Robert A. Michael—the company’s current president and chief operating officer—to succeed Richard A. Gonzalez as chief executive officer. Michael also will ...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more